The strength of immune responses after the first dose of COVID-19 vaccines could make or break this strategy and policy makers need to be able to adapt.
Vaccination by inhalation
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.
“Evolution‐on‐a‐chip” device helps reveal mutations that lead to superbugs
A well-based microfluidic device allows researchers to generate important data that are needed to better understand the parameters that influence evolution in bacteria to combat antibiotic resistance.
What COVID-19 vaccine should I get? Whichever one you are offered, say experts
First and foremost, the goal is to keep people out of hospitals. The good news is all of the currently approved vaccines do just that.
What is CRISPR?
Here we take a look at how CRISPR, the revolutionary “molecular scissors”, works and where its being used.
Protein synthesis: An adaptive “hive mind” of cellular proportions
New evidence suggests a hidden “intelligence” of a life-sustaining pathway.
Are nanoscale sensors the future for sepsis diagnosis?
Recent advances in micro- and nanoscale sensing technologies may help diagnose sepsis early and with greater accuracy.
Researchers discover potential SARS-CoV-2 inhibitors
New active substances that can block the replication of the SARS-CoV-2 coronavirus discovered in proof-of-concept study.
Biodegradable masks could help curb the rise in plastic waste
Moisture-resistant mask filters made from compostable and abundant materials could help curb plastic pollution as a result of the pandemic.
Russian COVID-19 vaccine shows 91.6% efficacy in phase 3 trial
Russia’s Sputnik V coronavirus vaccine gives around 92% protection against COVID-19, results published in The Lancet reveal.